Trials / Completed
CompletedNCT01644981
Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 2 Weeks – 4 Months
- Healthy volunteers
- Accepted
Summary
Serial quantitative measurements of plasma pro-endothelin-1 concentrations in very preterm infants. Comparing pro-endothelin-1 with established clinical indices of bronchopulmonary dysplasia (BPD). Hypothesis: Pulmonary-vascular remodeling in infants developing BPD is directly related to circulating pro-endothelin-1, which therefore serves as surrogate marker of BPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood sampling | blood sampling |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-09-01
- Completion
- 2013-12-01
- First posted
- 2012-07-19
- Last updated
- 2016-05-10
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01644981. Inclusion in this directory is not an endorsement.